1479r - Substitution of 68Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369

Page last updated: 27 November 2017

Application Detail



Description of Medical Service

68Ga-DOTA-peptide positron emission tomography (PET) / computed tomography (CT) scanning has been performed in lieu of 111In-octreotide single-photon emission computed tomography (SPECT)/CT for several years in a number of Australian public hospitals.

Description of Medical Condition

Patients with gastroenteropancreatic neuroendocrine tumours.

Reason for Application

New MBS item

Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


Consultation Survey


PICO Confirmation


Assessment Report

Assessment Report (Word 1744 KB)
Assessment Report (PDF 3055 KB)

Public Summary Document

Public Summary Document (Word 96 KB)
Public Summary Document (PDF 286 KB)

Meetings for this Application

Not Applicable






6-7 April 2017